Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Embellence Group AB (publ) in connection with the listing on Nasdaq First North Premier Growth Market
Mandate

Vinge advises Embellence Group AB (publ) in connection with the listing on Nasdaq First North Premier Growth Market

March 26, 2021 Banking and Finance Corporate Tax M&A Capital Markets and Public M&A

Vinge advises Embellence Group AB (publ) (“Embellence Group”) in connection with the listing on Nasdaq First North Premier Growth Market. The offering circular was published on 15 March 2021 and first day of trading was on 24 March 2021.

The offering price was SEK 42, corresponding to a market value of Embellence Group of approximately SEK 900 million. The offering comprised approximately 10.8 million shares, corresponding to a value of approximately SEK 454 million, provided that the overallotment option is exercised in its entirety.

Embellence Group, founded in 1905 in Borås, Sweden, is a leding European company in interior decoration, with a focus on premium brands within wallpaper, textile, rugs and other interior decoration with sales in over 90 countries. The company’s brand portfolio includes Cole & Son, Wall&decò, Perswall, Pappelina and Boråstapeter.

Vinge’s team mainly consisted of Johan Winnerblad, Jesper Schönbeck, Rikard Lindahl, Joel Magnusson, Linnea Petersson and Louise Brorsson Salomon, Pauline Lagerstrand and Rebecka Målquist regarding financing matters and Mattias Schömer and Henrik Wastenson regarding tax matters.

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025